Compound information
- Natural Products
- ZC244641
- Molecular Formula
- C21H32N6O4
- Molecular Weight
- 432.248503504 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1S)-1-[(2R)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamate
- InChI
- InChI=1S/C21H32N6O4/c1-2-24-18(28)17-11-7-13-27(17)19(29)16(10-6-12-25-20(22)23)26-21(30)31-14-15-8-4-3-5-9-15/h3-5,8-9,16-17H,2,6-7,10-14H2,1H3,(H,24,28)(H,26,30)(H4,22,23,25)/t16-,17+/m0/s1
- InChI Key
- SNPXWSQIUYYBIV-DLBZAZTESA-N
- SMILES
- CCNC(=O)[C@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1
- Source
- ZINC000102196776
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 31 | Ring Count | 2 |
Heteroatom Count | 10 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 5 |
Topological Polar Surface Area | 149.64 Å2 | LogP | 0.153 |
LogS | -2.233 | LogD | 0.742 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.02 | Pgp substrate | 0.997 |
HIA | 0.014 | F20 % | 0.854 |
F30 % | 0.0 | Caco-2 | -5.864 |
MDCK | -5.364 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.8 | PPB | 41.922 |
VD | 0.783 | Fu | 0.033 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.68 |
CYP2A6 substrate | 0.356 | CYP2B6 substrate | 0.556 |
CYP2C19 inhibitor | 0.068 | CYP2C19 substrate | 0.828 |
CYP2C8 substrate | 0.597 | CYP2C9 inhibitor | 0.195 |
CYP2C9 substrate | 0.081 | CYP2D6 inhibitor | 0.006 |
CYP2D6 substrate | 0.894 | CYP2E1 substrate | 0.299 |
CYP3A4 inhibitor | 0.039 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.733 | CL | 4.747 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.086 | Hepatotoxicity | 0.027 |
Mutagenicity | 0.038 | Rat Oral Acute Toxicity | 0.132 |
FDAMDD | 0.292 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.001 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.496 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.982 | IGC50 | 2.163 |
LC50FM | 0.139 | LC50DM | -3.412 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.16 | NR-AR-LBD | 0.243 |
NR-AhR | 0.003 | NR-Aromatase | 0.021 |
NR-ER | 0.258 | NR-ER-LBD | 0.375 |
NR-PPAR-gamma | 0.199 | SR-ARE | 0.114 |
SR-ATAD5 | 0.283 | SR-HSE | 0.137 |
SR-MMP | 0.007 | SR-p53 | 0.025 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.